CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant

Conditions

• Hematopoietic and Lymphoid Cell Neoplasm

Interventions

• OTHER: Best Practice
• DRUG: Clostridium butyricum CBM 588 Probiotic Strain

Sponsor

City of Hope Medical Center

Collaborators

• [object Object]